Patent Assignment
Reel/Frame 070442/0908
Security Interest
Recorded: 2025-03-07
Pages: 6
Assignors
CURIA GLOBAL, INC.
Executed: 2025-03-07
CURIA IP HOLDINGS, LLC
Executed: 2025-03-07
CURIA BIO, INC.
Executed: 2025-03-07
Assignee
APOLLO ADMINISTRATIVE AGENCY LLC
9 WEST 57TH STREET, NEW YORK, NEW YORK, 10019
Covered Properties
(16)
Aryl- and Heteroaryl-Substituted Tetrahydroisoquinolines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Aryl- and Heteroaryl-Substituted Tetrahydroisoquinolines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Aryl- and Heteroaryl-Substituted Tetrahydroisoquinolines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Crystalline Form of 6-[(4S)-2-Methyl-4-(2-Naphthyl)-1,2,3,4-Tetrahydroisoquinolin-7-Yl]Pyridazin-3-Amine
Tetrahydroisoquinolines and Intermediates Therefor
Aryl- and Heteroaryl-Substituted Tetrahydroisoquinolines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Crystalline Form of 6-[(4S)-2-Methyl-4-(2-Naphthyl)-1,2,3,4-Tetrahydroisoquinolin-7-Yl]Pyridazin-3-Amine
Aryl- and Heteroaryl-Substituted Tetrahydroisoquinolines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Aryl- and Heteroaryl-Substituted Tetrahydroisoquinolines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Crystalline Form of 6-[(4S)-2-Methyl-4-(2-Naphthyl)-1,2,3,4-Tetrahydroisoquinolin-7-Yl]Pyridazin-3-Amine
Ultrapure Tetrahydrocannabinol-11-Oic Acids
Ultrapure Tetrahydrocannabinol-11-Oic Acids
Sars-Cov-2 Spike Protein Antibodies
Application:
17/746,859 →
Publication:
US 2023/0115257
5-HT3 Receptor Modulator, the Crystalline Form, Methods of Making, and Use Thereof
Application:
17/904,144 →
Publication:
US 2023/0105412
Polymorphic Mixture of Rifaximin and Its Use for the Preparation of Solid Formulations
Application:
18/127,839 →
Publication:
US 2023/0234966
Sars-Cov-2 Spike Protein Antibodies
Application:
18/561,635 →
Publication:
US 2024/0239875
Related Assignments
(22)
Other recorded transfers of the patents in this record — the chain of ownership.
Release of Security Interest
Jul 9, 2014
From: WELLS FARGO
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 033283/0357 →
Security Interest
Oct 24, 2014
From: ALBANY MOLECULAR RESEARCH, INC.; ALO ACQUISITION LLC; AMRI BURLINGTON, INC.; AMRI RENSSELAER, INC.
To: BARCLAYS BANK PLC, AS THE COLLATERAL AGENT
Reel/Frame 034045/0951 →
Security Interest
Aug 5, 2015
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI SSCI, LLC
To: BARCLAYS BANK PLC, AS THE COLLATERAL AGENT
Reel/Frame 036257/0914 →
Assignment of Assignor's Interest
Jun 22, 2016
From: BRISTOL-MYERS SQUIBB COMPANY
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 039116/0827 →
Assignment of Assignor's Interest
Apr 25, 2017
From: TEPPER, MARK
To: CORBUS PHARMACEUTICALS, INC.
Reel/Frame 042133/0908 →
Release of Security Interest
Aug 31, 2017
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: ALBANY MOLECULAR RESEARCH, INC.; ALO ACQUISITION LLC; AMRI BURLINGTON, INC.; AMRI RENSSELAER, INC.
Reel/Frame 043742/0085 →
Second Lien Security Agreement
Sep 1, 2017
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; CEDARBURG PHARMACEUTICALS, INC.; EUTICALS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 043746/0657 →
First Lien Security Agreement
Sep 1, 2017
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; CEDARBURG PHARMACEUTICALS, INC.; EUTICALS INC.
To: BARCLAYS BANK, PLC AS COLLATERAL AGENT
Reel/Frame 043746/0621 →
Corrective Assignment to Correct the Incorrect Patent No. 7541537 Previously Recorded at Reel: 034045 Frame: 0951. Assignor(S) Hereby Confirms the Security Interest.
Aug 14, 2018
From: ALBANY MOLECULAR RESEARCH, INC.; ALO ACQUISITION LLC; AMRI BURLINGTON, INC.; AMRI RENSSELAER, INC.
To: BARCLAYS BANK PLC, AS THE COLLATERAL AGENT
Reel/Frame 046796/0352 →
Assignment of Assignor's Interest
Aug 27, 2018
From: FREY, DEAN A.; GOEDDEL, DAVID; REINEKE, KARL E.
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 046713/0858 →
Assignment of Assignor's Interest
Aug 27, 2018
From: ALBANY MOLECULAR RESEARCH, INC.
To: CORBUS PHARMACEUTICALS, INC.
Reel/Frame 046713/0955 →
Assignment of Assignor's Interest
Aug 13, 2019
From: TEPPER, MARK
To: CORBUS PHARMACEUTICALS, INC.
Reel/Frame 050041/0178 →
Assignment of Assignor's Interest
Aug 13, 2019
From: ALBANY MOLECULAR RESEARCH, INC.
To: CORBUS PHARMACEUTICALS, INC.
Reel/Frame 050041/0368 →
Assignment of Assignor's Interest
Aug 13, 2019
From: FREY, DEAN A.; GOEDDEL, DAVID; REINEKE, KARL E.
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 050041/0315 →
Release of Security Interest
Oct 29, 2020
From: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
To: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; CEDARBURG PHARMACEUTICALS, INC.; EUTICALS INC.
Reel/Frame 054252/0687 →
Release of Security Interest
Nov 16, 2020
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 054382/0326 →
Assignment of Assignor's Interest
Aug 15, 2022
From: GUZZO, PETER
To: CURIA GLOBAL INC.
Reel/Frame 060804/0719 →
Assignment of Assignor's Interest
Aug 15, 2022
From: MANNING, DAVID
To: CURIA GLOBAL INC.
Reel/Frame 060804/0554 →
Assignment of Assignor's Interest
May 18, 2023
From: ZABEL, BRIAN A.; LUO, DAN; ZHANG, LING; KANNEGANTI, VYDEHI
To: CURIA BIO, INC.
Reel/Frame 063685/0396 →
Change of Name
May 20, 2025
From: ALBANY MOLECULAR RESEARCH, INC.
To: CURIA GLOBAL, INC.
Reel/Frame 071298/0097 →
Second Lien Intellectual Property Security Agreement Supplement
Jun 2, 2025
From: CURIA GLOBAL, INC.; CURIA IP HOLDINGS, LLC; CURIA BIO, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 071490/0782 →
Partial Release of First Lien Intellectual Property Security Agreement Supplement
Jun 3, 2025
From: APOLLO ADMINISTRATIVE AGENCY LLC
To: CURIA GLOBAL, INC.
Reel/Frame 071490/0880 →